Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleClinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- Where
- Cincinnati, Denver, Durham, El Paso, Nashville, San Antonio, Torrance, Washington D.C.
- Age
- 1 year to 100 years
- People
- 40
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05868629 - No phaseTaking peopleEfficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
- Where
- San Francisco
- Age
- 2 years to 25 years
- People
- 40
- Run by
- University of California, San Francisco
See details and how to joinNCT07506239 - No phaseTaking peopleStudy of Personalized Cancer Therapy to Determine Response and Toxicity
- Where
- La Jolla, Rancho Mirage, San Diego
- Age
- 7 years and over
- People
- 10,000
- Run by
- Shu Mei Kato
See details and how to joinNCT02478931 - Phase 2Not yet taking people in United StatesRandomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
- Where
- Boston
- People
- 140
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07499999 - No phaseTaking peopleUsing Middle School Science Teachers to Address Cancer Health Disparities
- Where
- Brooklyn, New York, Queens, The Bronx
- Age
- 10 years and over
- People
- 1,812
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT07501689 - No phaseTaking peopleWhole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- Where
- Boston
- People
- 354
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02610413 - No phaseTaking peopleWhole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- Where
- Boston
- People
- 162
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02610426 - No phaseTaking peopleWhole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- Where
- Boston
- People
- 575
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02610439 - Phase 1Taking peopleStudy of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
- Where
- Atlanta, Chapel Hill
- Age
- 18 months and over
- People
- 18
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT03721068 - No phaseTaking peopleLi-Fraumeni & TP53 (LiFT UP): Understanding and Progress
- Where
- Boston
- People
- 1,500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04541654 - Phase 1/2Taking peopleCo-administration of CART22-65s and huCART19 for B-ALL
- Where
- Philadelphia
- Age
- Up to 29 years
- People
- 93
- Run by
- Stephan Grupp MD PhD
See details and how to joinNCT05674175 - No phaseTaking peopleIdentification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 8 years and over
- People
- 650
- Run by
- Mayo Clinic
See details and how to joinNCT06207188 - Phase 2Taking peopleCAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- Where
- Memphis
- Age
- Up to 21 years
- People
- 25
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06847269 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Baltimore, Boston, Buffalo, Chapel Hill, Charleston, Charlottesville, Chicago, Columbus, Denver, Durham, Eugene, Fairfax, Houston, Miami, Morristown, Nashville, New Brunswick, Newport Beach, New York, Norfolk, Palo Alto, Philadelphia, Pittsburgh, Salt Lake City, Tampa, Washington D.C., Winston-Salem
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseTaking peopleNeuroblastoma Biology Study
- Where
- Ann Arbor, Atlanta, Aurora, Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Dallas, Fort Worth, Los Angeles, Memphis, Palo Alto, Philadelphia, San Francisco, Seattle
- Age
- 31 days to 99 years
- People
- 1,000 worldwide
- Run by
- New Approaches to Neuroblastoma Therapy Consortium
See details and how to joinNCT01587300 - No phaseEnrolling by invitationProspective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
- Where
- Aurora
- Age
- 30 days to 21 years
- People
- 250
- Run by
- University of Colorado, Denver
See details and how to joinNCT03610906 - No phaseTaking peopleA Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
- Where
- Huntersville
- Age
- 5 years and over
- People
- 1,500
- Run by
- BioCytics, Inc.
See details and how to joinNCT00571389 - No phaseTaking peopleRelapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
- Where
- Cincinnati
- People
- 500
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT05556642 - No phaseTaking peopleDetailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
- Where
- Seattle
- People
- 100
- Run by
- University of Washington
See details and how to joinNCT06725173 - Early phase 1Taking peopleSingle Arm Romiplostim to Prevent CIT
- Where
- Cincinnati, Phoenix
- Age
- 1 year and over
- People
- 26
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT07048249 - Phase 1Taking peoplerHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Where
- Boston, Chicago, Orange
- Age
- 12 months to 18 years
- People
- 36
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
See details and how to joinNCT04943848 - Phase 2Taking peopleA Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 6 years to 49 years
- People
- 45
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07477457 - No phaseTaking peopleUpfront Surgical Resection for Osteosarcoma
- Where
- The Bronx
- Age
- 5 years to 40 years
- People
- 10
- Run by
- Montefiore Medical Center
See details and how to joinNCT06384404 - Phase 1Taking peopleA Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Where
- Boston, Chicago, Duarte, Houston, Nashville, New York, Palo Alto, Philadelphia, St Louis, Tampa
- Age
- 12 years and over
- People
- 72
- Run by
- Crossbow Therapeutics, Inc.
See details and how to joinNCT06994676 - Phase 2Taking peopleReduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Where
- Baltimore, The Bronx, Valhalla
- Age
- 1 year to 50 years
- People
- 60
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT01804634